The Federal Circuit Court controls all U.S. pharmaceutical patent appeals, shaping how generics enter the market, how patents are enforced, and whether new dosing regimens can be protected. Its rulings impact drug prices, litigation costs, and innovation.
Dec, 4 2025
Jan, 21 2026
